readthroughSign in
CompanyKURANasdaqSan Diego, CA

Kura Oncology, Inc.

Kura Oncology develops small molecule drugs targeting cancer signaling pathways for hematologic malignancies and solid tumors.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story